Nuzenio

Approve Share Issue

Approve Share Issue news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Aptus Pharma approves 16.1 lakh share preferential allotment to 192 investors - scanx.tradescanx.trade · Sat, 08 Aug 2026 12:41:28 GMT Mukka Proteins shareholders approve ₹47 crore preferential warrant issue - scanx.tradescanx.trade · Sat, 08 Aug 2026 12:00:29 GMT Jindal Worldwide seeks approval for ₹650 Cr rights issue at AGM - scanx.tradescanx.trade · Sat, 08 Aug 2026 06:55:59 GMT Jindal Worldwide Approves Rs 650 Cr Rights Issue To Fund Growth - BW BusinessworldBW Businessworld · Fri, 07 Aug 2026 12:05:46 GMT Jindal Worldwide Approves Rs 650 Cr Rights Issue - EquitypanditEquitypandit · Fri, 07 Aug 2026 12:00:42 GMT Jindal Worldwide board approves ₹650 crore fundraising through rights issue - CNBC TV18CNBC TV18 · Fri, 07 Aug 2026 10:39:23 GMT Kabra Extrusiontechnik Board Approves ₹120 Crore Preferential Share Issue - scanx.tradescanx.trade · Fri, 07 Aug 2026 10:06:29 GMT Kabra Extrusiontechnik Board Approves ₹120 Crore Preferential Issue of 32 Lakh Shares - SahiSahi · Fri, 07 Aug 2026 09:51:02 GMT

Timeline

Sat, 08 Aug 2026 12:41:28 GMTAptus Pharma approves 16.1 lakh share preferential allotment to 192 investors - scanx.trade

Sat, 08 Aug 2026 12:00:29 GMTMukka Proteins shareholders approve ₹47 crore preferential warrant issue - scanx.trade

Sat, 08 Aug 2026 06:55:59 GMTJindal Worldwide seeks approval for ₹650 Cr rights issue at AGM - scanx.trade

Fri, 07 Aug 2026 12:05:46 GMTJindal Worldwide Approves Rs 650 Cr Rights Issue To Fund Growth - BW Businessworld

Fri, 07 Aug 2026 12:00:42 GMTJindal Worldwide Approves Rs 650 Cr Rights Issue - Equitypandit

Fri, 07 Aug 2026 10:39:23 GMTJindal Worldwide board approves ₹650 crore fundraising through rights issue - CNBC TV18

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

Approves8 live mentions Jindal Worldwide6 live mentions Ratify Share Issues6 live mentions General Meeting5 live mentions Cr Rights Issue4 live mentions Crore Preferential Share4 live mentions Bonus Issue4 live mentions CNBC3 live mentions Kabra Extrusiontechnik Board3 live mentions Sahi3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Approve Share Issue.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.